Name | Role | Date | Shares | Price | Value |
---|---|---|---|---|---|
Charles N. York Ii | COO and CFO | 2025-08-18 | 4,106 | $6.77 | $27.79kSell |
Adam Dubow | Gen Counsel Secretary | 2025-08-18 | 4,365 | $6.77 | $29.54kSell |
Lauren Merendino | Chief Commercial Officer | 2025-08-18 | 3,766 | $6.77 | $25.48kSell |
Jeremy Bender | CHIEF EXECUTIVE OFFICER | 2025-08-18 | 16,058 | $6.77 | $108.66kSell |
Adam Dubow | GENERAL COUNSEL | 2025-05-16 | 4,552 | $6.26 | $28.49kSell |
Jeremy Bender | CHIEF EXECUTIVE OFFICER | 2025-05-16 | 13,964 | $6.26 | $87.39kSell |
Charles N. York Ii | COO CFO AND SECRETARY | 2025-05-16 | 4,282 | $6.26 | $26.80kSell |
Lauren Merendino | Chief Commercial Officer | 2025-05-16 | 3,927 | $6.26 | $24.58kSell |
Adam Dubow | GENERAL COUNSEL | 2025-02-18 | 4,646 | $11.96 | $55.58kSell |
Jeremy Bender | CHIEF EXECUTIVE OFFICER | 2025-02-18 | 12,048 | $11.96 | $144.13kSell |
Name | Hold | Shares | Value | Type |
---|---|---|---|---|
Ai Day1 LLC | 12.62% | 12,929,322 | $97.10M | Insider |
Fmr LLC | 11.07% | 11,342,699 | $85.18M | Institution |
Papanek Julie Grant | 10.93% | 11,199,207 | $84.11M | Insider |
Blackrock Inc | 9.60% | 9,830,431 | $73.83M | Institution |
Ai Day 1 LLC | 9.16% | 9,377,776 | $70.43M | Insider |
Canaan XI LP | 6.80% | 6,964,301 | $52.30M | Insider |
Atlas Venture Life Science Advisors LLC | 6.28% | 6,430,257 | $48.29M | Institution |
Atlas Venture Fund XI LP | 6.11% | 6,258,534 | $47.00M | Insider |
Vanguard Group Inc | 6.03% | 6,176,495 | $46.39M | Institution |
Takeda Pharmaceutical Co Ltd | 5.97% | 6,120,124 | $45.96M | Insider |